ANATOMIC PATTERNS OF RELAPSE AND PROGRESSION FOLLOWING TREATMENT WITH 131I-MIBG IN METASTATIC NEUROBLASTOMA

被引：0
|
作者：
Ben Kenan, Fishel R. [1 ,2 ]
Polishchuk, A. [2 ]
Haas-Kogan, D. [2 ]
机构：
[1] UA COM Phoenix, Phoenix, AZ USA
[2] UCSF, San Francisco, CA USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2017年 / 65卷 / 01期
关键词：
D O I：
10.1136/jim-2016-000365.104
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
104
引用
收藏
页码：143 / 143
页数：1
相关论文
共 50 条
  • [41] The Therapeutic Effect of 131I-MIBG Focusing on the Lesions not Detected by a Conventional 123I-MIBG Scintigraphy in Neuroblastoma
    Araki, Raita
    Nishimura, Ryosei
    Fujiki, Toshihiro
    Inaki, Anri
    Wakabayashi, Hiroshi
    Noguchi, Kazuhiro
    Mase, Shintaro
    Kuroda, Rie
    Ikawa, Yasuhiro
    Maeba, Hideaki
    Sakai, Seisho
    Yachie, Akihiro
    Kinuya, Seigo
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S89 - S89
  • [42] 131I－MIBG标记条件研究
    陈大明，金小海，杜进，刘跃民，王凡
    同位素, 1995, (01) : 12 - 15
  • [43] 131I-MIBG with myeloablative chemotherapy for neuroblastoma:: A new approaches to neuroblastoma therapy (NANT) phase I study.
    Matthay, KK
    Yanik, G
    Tan, J
    Huberty, J
    Franc, B
    Villablanca, JG
    Reynolds, CP
    Groshen, S
    Seeger, RC
    Maris, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 801S - 801S
  • [44] Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)
    Zhou, Margaret J.
    Doral, Michelle Y.
    DuBois, Steven G.
    Villablanca, Judith G.
    Yanik, Gregory A.
    Matthay, Katherine K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (16) : 2465 - 2472
  • [45] Preparation and quality control of 131I-MIBG
    Huang, Y
    Liu, YS
    Tian, JC
    Song, DH
    PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON ISOTOPES: ISOTOPE PRODUCTION AND APPLICATIONS IN THE 21ST CENTURY, 2000, : 93 - 95
  • [46] High dose dosimetry-guided 131I-MIBG treatment for refractory primary neuroblastoma: a case report
    Boni, G.
    Borso, E.
    Mazzarri, S.
    Menconi, M.
    Casazza, G.
    Favre, C.
    Traino, C. A.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S532 - S532
  • [47] Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with 131I-meta-iodobenzylguanidine (131I-mIBG)
    Mukherjee, JJ
    Kaltsas, GA
    Islam, N
    Plowman, PN
    Foley, R
    Hikmat, J
    Britton, KE
    Jenkins, PJ
    Chew, SL
    Monson, JP
    Besser, GM
    Grossman, AB
    CLINICAL ENDOCRINOLOGY, 2001, 55 (01) : 47 - 60
  • [48] HIGH DOSE 131I-MIBG TREATMENT IN STAGE 4 NEUROBLASTOMA PATIENTS IN A TERTIARY CENTRE IN HONG KONG
    Leung, W. K.
    Lee, V.
    Kam, M. K. M.
    Cheung, J. S. S.
    Cheng, F. W. T.
    Shing, M. K.
    Li, C. K.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 111 - 112
  • [49] Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
    DuBois, S. G.
    Allen, S.
    Bent, M.
    Hilton, J. F.
    Hollinger, F.
    Hawkins, R.
    Courtier, J.
    Mosse, Y. P.
    Matthay, K. K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (04) : 644 - 649
  • [50] Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
    S G DuBois
    S Allen
    M Bent
    J F Hilton
    F Hollinger
    R Hawkins
    J Courtier
    Y P Mosse
    K K Matthay
    British Journal of Cancer, 2015, 112 : 644 - 649
12345